The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant

被引:43
|
作者
Liu, Xiuping [1 ]
Wetzler, Lee M. [1 ]
Massari, Paola [1 ]
机构
[1] Boston Univ, Sch Med, Evans BioMed Res Ctr, Dept Med Sect Infect Dis, Boston, MA 02118 USA
关键词
adjuvant; immune stimulation; commensal bacteria; porin;
D O I
10.1016/j.vaccine.2007.11.080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porins from pathogenic Neisseriae are among several bacterial products with immune adjuvant activity. Neisseria meningitidis (Nme) PorB, has been shown to induce immune cells activation in a TLR2-dependent manner and acts as a vaccine immune adjuvant. The PorB porin from Neisseria lactamica (Nlac), a common nasopharyngeal commensal, shares significant structural and functional similarities with Nme PorB. In this work we ask whether the immune adjuvant ability of porins from pathogenic Neisserial strains is a characteristic shared with porins from non-pathogenic Neisserial species or whether it is unique for bacterial products derived from microorganisms capable of inducing inflammation and disease. We evaluated the potential immune adjuvant effect of Nlac PorB in mice using ovalbumin (OVA) as a prototype antigen. Immunization with Nlac PorB/OVA induced high OVA-specific IgG and IgM titers compared to OVA alone, similar to other adjuvants such as Nme PorB and alum. High titers of IgG1 and IgG2b were detected as well as production of IL-4, IL-10, IL-12 and INF-gamma in response to Nlac PorB, consistent with induction of both a Th1-type and a Th2-type immune response. OVA-specific proliferation was also determined in splenocytes from Nlac PorB/OVA-immunized mice. In addition, B cell activation in vitro and cytokine production in response to Nlac PorB was found to be mediated by TLR2, in a similar manner to Nme PorB. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 50 条
  • [1] Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice
    Yuan, Lin
    Wu, Lihua
    Chen, Jian
    Wu, Qiang
    Hu, Songhua
    VACCINE, 2010, 28 (27) : 4402 - 4410
  • [2] Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice
    Yang, Zhigang
    Chen, Aqin
    Sun, Hongxiang
    Ye, Yiping
    Fang, Weihuan
    VACCINE, 2007, 25 (01) : 161 - 169
  • [3] Chitosan Nanoparticles Act as an Adjuvant to Promote both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice
    Wen, Zheng-Shun
    Xu, Ying-Lei
    Zou, Xiao-Ting
    Xu, Zi-Rong
    MARINE DRUGS, 2011, 9 (06): : 1038 - 1055
  • [4] Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice
    Matsumura, Misa
    Nagata, Masafumi
    Nakamura, Kazuichi
    Kawai, Motoyuki
    Baba, Takahiko
    Yamaki, Kouya
    Yoshino, Shin
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2010, 32 (01) : 56 - 62
  • [5] Effect of methotrexate on Th1 and Th2 immune responses in mice
    Yamaki, K
    Uchida, H
    Harada, Y
    Li, XJ
    Yanagisawa, R
    Takano, H
    Hayashi, H
    Taneda, S
    Mori, Y
    Yoshino, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (12) : 1661 - 1666
  • [6] Immune modulation (TH1 and TH2 responses) in pregnancy
    Russell, AS
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1998, : 14 - 17
  • [7] Regulation of Th1 and Th2 immune responses by chemokines
    Yoneyama, H
    Kawasaki, S
    Matsushima, K
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2000, 22 (04): : 329 - 344
  • [8] TH1/TH2 immune response
    Dechene, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) : 539 - 540
  • [9] Role and development of Th1/Th2 immune responses in the lungs
    Herring, AC
    Hernández, Y
    Huffnagle, GB
    Toews, GB
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (01) : 3 - 10
  • [10] Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses
    Xie, Yong
    Deng, Wen
    Sun, Hongxiang
    Li, Duo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (08) : 1143 - 1150